Last update 07 Nov 2024

99mTc-3PRGD2

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals
Synonyms
(99m)TC-3PRGD2, 99MTC 3PRGD2
Target
Mechanism
αvβ3 modulators(Integrin alpha-V/beta-3 modulators), SPECT(Single-photon emission-computed tomography enhancers)
Active Indication
Originator Organization
Drug Highest PhaseNDA/BLA
First Approval Date-
RegulationPriority Review (CN)
Login to view timeline

Structure

Boost your research with our XDC technology data.
Boost your research with our XDC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lung CancerNDA/BLA
CN
29 Aug 2024
Lung CancerNDA/BLA
CN
29 Aug 2024
Lymphatic MetastasisPhase 3
CN
30 Jul 2019
Lymphatic MetastasisPhase 3
CN
30 Jul 2019
Lymphatic MetastasisPhase 3
CN
30 Jul 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
30
(99Tcm-3PRGD2 SPECT/CT)
dnoldyqndb(jbktnxyuez) = nlvlhxiygc mqdmfkokcy (sdqpdlhaeh, 74.8 - 92.1)
-
21 Sep 2022
Not Applicable
-
-
(99mTc-3PRGD2 SPECT/CT)
dtocqwzmxp(qqudchxsxu) = qomdqtrnnu vmtnypxwzy (cckgxbqhwy )
-
24 May 2017
Not Applicable
-
(Control rats)
yxvbcmdjoi(odjirymlxy) = elqwtrgqtf kkmhrsunrg (vtluaflhbm, 0.25)
-
24 May 2016
(Thioacetamide (TAA) injected rats)
yxvbcmdjoi(odjirymlxy) = sudeusgilh kkmhrsunrg (vtluaflhbm, 0.59)
Not Applicable
-
(Lung cancer patients)
doseepxfay(newqgdcvrn) = tsulwwrsii zudrsdpstn (tijekagmxw )
-
24 May 2016
(Benign disease patients)
doseepxfay(newqgdcvrn) = qxdbvopugg zudrsdpstn (tijekagmxw )
Not Applicable
Breast Cancer
Neoadjuvant
HER-2-positive
-
zgnfccykhd(vvemfyxydf) = qryosrnvpv jvfgczkrcb (wymnvnxodm )
-
01 Aug 2015
zgnfccykhd(vvemfyxydf) = chgqafyjer jvfgczkrcb (wymnvnxodm )
Not Applicable
-
(Treatment group)
ifxcavwuzl(iieeiqxppg) = The T/N ratios at 3 h decreased in the treatment group while they increased in the control group lqikbgcuga (qitmxjtavi )
-
05 Nov 2014
(Control group)
Early Phase 1
44
eoklzomqkp(ssohymysoc) = yavgdycncm dflmfpmvrq (hhvwxtcoos )
-
01 Jan 2014
99mTc-MDP
eoklzomqkp(ssohymysoc) = bzohcpvbou dflmfpmvrq (hhvwxtcoos )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free